Samsung Biologics raises annual estimated earnings to W3.6t

发布时间：2023-12-07 14:57:56 作者：玩站小弟

Samsung Biologics has raised the full-year earnings estimate in its company guidance again to 3.6 tr 。

Samsung Biologics has raised the full-year earnings estimate in its company guidance again to 3.6 trillion won ($2.6 billion) for this year, up some 20 percent from last year, according to its regulatory filing released on Wednesday.

It was the second time this year for Samsung Biologics to increase the estimate of its annual earnings. Earlier in April, the company raised its estimated earnings from sales to 3.52 trillion won.

“(Samsung Biologics) has readjusted (the estimated earnings in its) annual company guidance again, mainly based on large-sized contract manufacturing orders from international pharmaceutical companies this year,” an official from Samsung Biologics said.

In 2023, the company’s accumulated order value reached some 2.7 trillion won, backed by its large-scale contracts with Pfizer, Novartis and BMS.

Many of its clients, including GSK, Roche, Novartis, Pfizer and Eli Lilly, have also agreed with Samsung Biologics to expand their existing contract manufacturing deals, helping the company to post improved earnings this year.

The combined value of deals that have been expanded from existing deals has reached 986.2 billion won as of September, according to Samsung Biologics.

Samsung Biologics expects its earnings to improve particularly in the third quarter, in which revenue from the company’s fourth plant will start to be included.

“The utilization rate of the fourth plant has been increasing faster than expected,” the official from Samsung Biologics said.

Tag： %E8%9A%8C%E5%9F%A0%E4%BD%93%E8%82%B2%E5%9C%BA%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%9A%8C%E5%9F%A0%E4%BD%93%E8%82%B2%E5%9C%BA%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%9A%8C%E5%9F%A0%E4%BD%93%E8%82%B2%E5%9C%BA%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%9A%8C%E5%9F%A0%E4%BD%93%E8%82%B2%E5%9C%BA%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E8%B6%B3%E7%90%83%E5%9F%8E%E5%B8%82%E5%AF%B9%E6%8A%97%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%B6%B3%E7%90%83%E5%9F%8E%E5%B8%82%E5%AF%B9%E6%8A%97%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E5%9F%8E%E5%B8%82%E5%AF%B9%E6%8A%97%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BEapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E5%9F%8E%E5%B8%82%E5%AF%B9%E6%8A%97%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E9%BE%99%E7%8F%A0%E7%9B%B4%E6%92%AD%E5%90%A7%E5%85%8D%E8%B4%B9%E8%A7%82%E7%9C%8B%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E9%BE%99%E7%8F%A0%E7%9B%B4%E6%92%AD%E5%90%A7%E5%85%8D%E8%B4%B9%E8%A7%82%E7%9C%8B%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E9%BE%99%E7%8F%A0%E7%9B%B4%E6%92%AD%E5%90%A7%E5%85%8D%E8%B4%B9%E8%A7%82%E7%9C%8Bapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E9%BE%99%E7%8F%A0%E7%9B%B4%E6%92%AD%E5%90%A7%E5%85%8D%E8%B4%B9%E8%A7%82%E7%9C%8B%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E8%91%A1%E8%90%84%E7%89%99%E8%B6%B3%E7%90%83%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E8%A7%86%E9%A2%91%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%91%A1%E8%90%84%E7%89%99%E8%B6%B3%E7%90%83%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E8%A7%86%E9%A2%91%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%91%A1%E8%90%84%E7%89%99%E8%B6%B3%E7%90%83%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E8%A7%86%E9%A2%91app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%91%A1%E8%90%84%E7%89%99%E8%B6%B3%E7%90%83%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E8%A7%86%E9%A2%91%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E6%B5%B7%E7%99%BB%E6%B5%B7%E5%A7%86%E8%B6%B3%E7%90%83vs%E5%9F%BA%E8%89%BA%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E6%B5%B7%E7%99%BB%E6%B5%B7%E5%A7%86%E8%B6%B3%E7%90%83vs%E5%9F%BA%E8%89%BA%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E6%B5%B7%E7%99%BB%E6%B5%B7%E5%A7%86%E8%B6%B3%E7%90%83vs%E5%9F%BA%E8%89%BA%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E6%B5%B7%E7%99%BB%E6%B5%B7%E5%A7%86%E8%B6%B3%E7%90%83vs%E5%9F%BA%E8%89%BA%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E4%B8%96%E7%95%8C%E6%9D%AF%E8%B6%B3%E7%90%83%E6%80%8E%E4%B9%88%E7%9C%8B%E7%9B%B4%E6%92%AD%E8%A7%86%E9%A2%91%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E4%B8%96%E7%95%8C%E6%9D%AF%E8%B6%B3%E7%90%83%E6%80%8E%E4%B9%88%E7%9C%8B%E7%9B%B4%E6%92%AD%E8%A7%86%E9%A2%91%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E4%B8%96%E7%95%8C%E6%9D%AF%E8%B6%B3%E7%90%83%E6%80%8E%E4%B9%88%E7%9C%8B%E7%9B%B4%E6%92%AD%E8%A7%86%E9%A2%91app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E4%B8%96%E7%95%8C%E6%9D%AF%E8%B6%B3%E7%90%83%E6%80%8E%E4%B9%88%E7%9C%8B%E7%9B%B4%E6%92%AD%E8%A7%86%E9%A2%91%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E6%AC%A7%E6%B4%B2%E6%9D%AF%E8%B6%B3%E7%90%83%E5%AE%98%E7%BD%91%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E6%AC%A7%E6%B4%B2%E6%9D%AF%E8%B6%B3%E7%90%83%E5%AE%98%E7%BD%91%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E6%AC%A7%E6%B4%B2%E6%9D%AF%E8%B6%B3%E7%90%83%E5%AE%98%E7%BD%91%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8Bapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E6%AC%A7%E6%B4%B2%E6%9D%AF%E8%B6%B3%E7%90%83%E5%AE%98%E7%BD%91%E7%9B%B4%E6%92%AD%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E5%B9%B3%E5%8F%B0%20-%E3%80%8B 9%E6%9C%8822%E6%97%A5%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F9%E6%9C%8822%E6%97%A5%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F9%E6%9C%8822%E6%97%A5%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BEapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F9%E6%9C%8822%E6%97%A5%E8%B6%B3%E7%90%83%E6%AF%94%E8%B5%9B%E7%9B%B4%E6%92%AD%E5%9B%9E%E6%94%BE%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E4%B9%8C%E6%8B%89%E5%9C%AD%E5%93%A5%E4%BC%A6%E6%AF%94%E4%BA%9A%E8%B6%B3%E7%90%83%E5%9C%A8%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E4%B9%8C%E6%8B%89%E5%9C%AD%E5%93%A5%E4%BC%A6%E6%AF%94%E4%BA%9A%E8%B6%B3%E7%90%83%E5%9C%A8%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E4%B9%8C%E6%8B%89%E5%9C%AD%E5%93%A5%E4%BC%A6%E6%AF%94%E4%BA%9A%E8%B6%B3%E7%90%83%E5%9C%A8%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E4%B9%8C%E6%8B%89%E5%9C%AD%E5%93%A5%E4%BC%A6%E6%AF%94%E4%BA%9A%E8%B6%B3%E7%90%83%E5%9C%A8%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B

Supporters of Israel hold rally in Seoul, urge Hamas to stop atrocities
Supporters of Israel took to the streets in Seoul on Tuesday, urging Hamas militants to stop their k
2023-12-07
[Today’s K
The teaser video for Seventeen’s 11th EP was brought down on Sunday, said agency Pledis Entertainmen
2023-12-07
Breadwinners in their 60s or above double in 9 years
More than one million Koreans aged over 60 are primary household earners, despite their age falling
2023-12-07
'코로나 봉쇄' 북한, 국경 열었다…3년8개월 만에 외국인 입국
중국 베이징 소재 북한전문 여행사 '고려투어'는 지난달 11일 홈페이지 게시글에서 "북한이 매우 조만간 국경을 공식 개방할 것으로 기대된다는 소식을 들었다"고 밝혔다. 사진은 고려
2023-12-07
Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US s
2023-12-07
N. Korea scheduled to hold key parliamentary meeting following Kim
North Korea is scheduled to convene a key parliamentary meeting Tuesday amid keen attention over whe
2023-12-07